跳至主要内容
临床试验/CTRI/2021/08/035809
CTRI/2021/08/035809尚未招募未知

An assessment of vidang rajanyadi ghanvati and haridradi tail matrabasti in madhumeh with special reference to diabetes mellitus type 2 in comparison with metformin- an open randomised controlled trial

Dr Manali Vijaysinha Deshmukh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Recently diagnosed patients of type 2 DM
  • patients irrespective of gender and who are willing to take medicine
  • Age group within 30-80 years
  • Patients with fasting blood sugar level more than 126mg/dl and post prandial more than 200mg/dl with presence of sugar in urine
  • Patients with HbA1C value more than 6.4%
  • Patients having sign and symptoms of Madhumeha

排除标准

  • K/C/O type 1 DM
  • Gestational Diabetes
  • K/C/0 Ketoacidosis, diabetic coma,acute infection anywhere in the body and gangrene
  • Patients on Insulin and steroid Therapy
  • Patients with any major systemic diseases like carcinoma tuberculosis
  • K/C/O immunocompromised patients or patients on immunosuppressant drugs
  • Emergency conditions

研究者

发起方
Dr Manali Vijaysinha Deshmukh

相似试验